Schizophrenia

Schizophrenia is a serious, chronic psychiatric disorder that typically emerges in late adolescence or early adulthood. It involves a combination of 'positive' symptoms — hallucinations, delusions, and disorganized speech or behavior that represent an excess or distortion of normal function — and 'negative' symptoms, such as reduced emotional expression, low motivation, and social withdrawal, which reflect a loss of normal function. Cognitive difficulties with memory, attention, and planning are also common and often have the greatest impact on long-term functioning. With modern treatment, many people achieve meaningful stability and quality of life, though outcomes vary considerably.

Schizophrenia requires two or more of the following, each present for a significant portion of time during a one-month period (at least one must be delusions, hallucinations, or disorganized speech): delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, and negative symptoms. Continuous signs of disturbance must persist for at least six months, including active-phase symptoms for at least one month, and there must be a significant decline in social or occupational functioning from a previous level.

Schizophrenia has one of the highest heritability estimates in psychiatry (around 80%), reflecting a polygenic combination of many genetic variants, and is understood through a neurodevelopmental model — subtle disruptions in early brain development that only become clinically apparent after the brain's natural adolescent maturation and synaptic pruning processes. Environmental contributors include obstetric complications, prenatal infection or malnutrition, heavy adolescent cannabis use, urban upbringing, and migration-related social adversity, each of which appears to interact with underlying genetic vulnerability rather than cause the illness alone.

• Family history of schizophrenia (risk increases with genetic relatedness to an affected relative)
• Obstetric complications or prenatal exposure to infection, malnutrition, or maternal stress
• Advanced paternal age at conception
• Heavy cannabis use during adolescence
• Urban birth or upbringing
• Migration and associated social adversity
• Childhood trauma or adversity

The dopamine hypothesis proposes that hyperactivity in the brain's mesolimbic dopamine pathway drives positive symptoms (hallucinations, delusions), while reduced dopamine activity in the mesocortical pathway contributes to negative and cognitive symptoms — explaining why antipsychotics, which block dopamine receptors, primarily improve positive symptoms. A complementary theory implicates glutamate/NMDA receptor hypofunction, supported by the observation that NMDA-antagonist drugs like ketamine can produce psychosis-like states. Neuroimaging commonly shows enlarged brain ventricles and reduced grey matter volume, consistent with the neurodevelopmental model.

• Hallucinations, most commonly auditory (hearing voices)
• Delusions — fixed, false beliefs such as persecutory, referential, or grandiose ideas
• Disorganized speech (loose associations, tangential or incoherent thinking)
• Grossly disorganized or catatonic behavior
• Flat or blunted emotional expression
• Alogia (reduced speech output)
• Avolition (reduced motivation to initiate or sustain purposeful activity)
• Social withdrawal and anhedonia
• Cognitive difficulties: impaired attention, working memory, and executive function

• Two or more of: delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, negative symptoms — each present for a significant portion of a 1-month period
• At least one of the two must be delusions, hallucinations, or disorganized speech
• Continuous signs of disturbance for 6+ months, including at least 1 month of active-phase symptoms (may include prodromal or residual periods with only negative or attenuated symptoms)
• Significant decline in social, occupational, or self-care functioning from a previous level
• Schizoaffective disorder and mood disorder with psychotic features have been ruled out
• Not attributable to a substance or another medical condition

Conditions a psychiatrist will consider and rule out before confirming this diagnosis:

Schizoaffective Disorder

Major mood episodes are present for the majority of the total illness duration, alongside psychosis, unlike schizophrenia where mood episodes, if present, are brief relative to the overall course.

Brief Psychotic Disorder

Psychotic symptoms last less than one month with a full return to baseline functioning, unlike the sustained course of schizophrenia.

Delusional Disorder

Involves delusions without the broader psychotic symptom picture or the functional decline typical of schizophrenia.

Substance-induced psychosis

Methamphetamine and heavy cannabis use, among others, can produce a psychotic picture that resolves once the substance is cleared, though sometimes it can trigger a lasting underlying illness in vulnerable individuals.

Bipolar Disorder with psychotic features

Psychotic symptoms occur only during manic or depressive episodes, not independently of a mood disturbance.

Autism Spectrum Disorder

Social withdrawal and flat affect can superficially resemble negative symptoms, but true hallucinations and delusions are absent.

Delirium

Distinguished by acute onset, fluctuating consciousness, and an identifiable underlying medical cause.

• Comprehensive psychiatric interview with collateral history from family where possible
• Physical examination and laboratory tests (thyroid function, vitamin B12, syphilis and HIV serology where clinically indicated) to exclude medical causes
• Urine toxicology screening
• Brain MRI or CT, particularly for a first episode, to exclude a structural cause
• Positive and Negative Syndrome Scale (PANSS) to assess symptom severity

Antipsychotic medication is the cornerstone of treatment for both acute episodes and long-term relapse prevention, combined with psychosocial interventions such as CBT for psychosis, family psychoeducation, and social skills training. Specialized early-intervention services for first-episode psychosis have been shown to significantly improve long-term outcomes, making prompt assessment and treatment initiation especially valuable.

Second-generation (atypical) antipsychotics (e.g., risperidone, olanzapine, quetiapine, aripiprazole)

Generally preferred first-line given a more favorable profile regarding movement-related side effects.

First-generation (typical) antipsychotics (e.g., haloperidol)

Still effective and used, though more prone to extrapyramidal side effects.

Clozapine

Reserved for treatment-resistant schizophrenia, requiring regular blood monitoring due to a risk of agranulocytosis, but often highly effective when other antipsychotics have failed.

Long-acting injectable antipsychotics

Improve treatment adherence by providing sustained medication levels over 2–12 weeks per injection.

Cognitive Behavioral Therapy for psychosis (CBTp)

Helps manage distress from hallucinations and delusions and improve coping strategies.

Family psychoeducation and therapy

Reduces relapse risk, particularly by lowering 'expressed emotion' — high levels of criticism, hostility, or over-involvement in the family environment.

Social skills training

Builds practical skills for social and occupational functioning.

Supported employment and education programs

Helps maintain or return to work/study alongside symptom management.

Cognitive remediation

Targets cognitive symptoms like memory and attention difficulties.

• Maintain consistent medication adherence, even during periods of stability
• Avoid cannabis and stimulant use, which can worsen psychotic symptoms
• Keep a structured daily routine
• Stay engaged with family and support networks
• Attend regular follow-up appointments, including physical health monitoring given the metabolic risks (weight gain, blood sugar, cholesterol) associated with many antipsychotics

Outcomes in schizophrenia are variable: roughly a third of people achieve good functional recovery, a third have moderate improvement with some residual symptoms, and a third experience persistent, significant impairment. Early intervention meaningfully improves outcomes, while medication non-adherence is strongly associated with relapse. Life expectancy is reduced compared to the general population, largely due to cardiovascular and metabolic health effects and elevated suicide risk, underscoring the importance of integrated physical and mental health care.

• Early intervention through specialized first-episode psychosis programs
• Reducing heavy cannabis use during adolescence, particularly in those with a family history of psychosis
• Family psychoeducation to reduce expressed emotion and lower relapse risk
• Consistent support for medication adherence

Understand schizophrenia as a chronic brain disorder requiring ongoing management, similar in some ways to a condition like diabetes. Learn about 'expressed emotion' — calm, supportive, low-criticism communication measurably reduces relapse risk compared to a highly critical or over-involved family environment. Support medication adherence without confrontation, avoid directly arguing with delusional beliefs (while also not reinforcing them), and watch for early warning signs of relapse. Caring for a family member with schizophrenia is demanding, and caregivers benefit from their own support and respite.

Practical ways families can support a relative with schizophrenia and reduce relapse risk, based on family psychoeducation principles.

1. Step 1: Understand it as a chronic, manageable brain disorder

   See schizophrenia as an ongoing medical condition requiring management, similar in some ways to a condition like diabetes, rather than a personal failing.

2. Step 2: Practice calm, low-criticism communication

   Reducing 'expressed emotion' — high criticism, hostility, or over-involvement — measurably lowers relapse risk compared to a highly critical family environment.

3. Step 3: Support medication adherence without confrontation

   Encourage consistent treatment gently and collaboratively rather than through pressure or arguments.

4. Step 4: Respond carefully to delusional beliefs

   Avoid directly arguing with delusional beliefs, while also not reinforcing them — acknowledge the person's distress without agreeing with the content.

5. Step 5: Watch for early warning signs of relapse

   Learn the person's individual early warning signs, and seek prompt follow-up care if they appear.

6. Step 6: Seek your own support as a caregiver

   Caring for a family member with schizophrenia is demanding. Build your own support network and take time for respite.

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR).
2. World Health Organization. International Classification of Diseases, 11th Revision (ICD-11).
3. National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in adults: prevention and management.
4. World Health Organization. Schizophrenia fact sheet.